found that silencing the LGALS1 gene in cancer-associated fibroblasts (CAFs) inhibited CAF-induced tumor cell migration and invasion in vitro, as well as tumor formation in vivo, suggesting that blocking the LGALS1 gene could be a potential approach for treating liver cancer (39). This evidence concerns the gene LGALS1 and liver cancer.